Bond AbbVie Inc. 4.25% ( US00287YCB39 ) in USD
Issuer | AbbVie Inc. |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 4.25% per year ( payment 2 times a year) |
Maturity | 20/11/2049 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 2 000 USD |
Total amount | 5 745 050 000 USD |
Cusip | 00287YCB3 |
Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) |
Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
Next Coupon | 21/05/2025 ( Today ) |
Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YCB39, pays a coupon of 4.25% per year. The coupons are paid 2 times per year and the Bond maturity is 20/11/2049 The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YCB39, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YCB39, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |